Date |
Title |
Format |
18/12/2001 |
Share Issue |
|
06/12/2001 |
Further fundraising |
|
19/11/2001 |
ReGen strengthen it’s Colostrinin™ IP rights |
|
06/11/2001 |
Directors shareholdings |
|
05/11/2001 |
Placing of ordinary shares |
|
30/10/2001 |
ReGen to acquire full ownership of its Colostrinin™ IP rights |
|
26/10/2001 |
Trial recruitment complete |
|
17/10/2001 |
Update on placing of ordinary shares |
|
11/10/2001 |
Placing of Ordinary Shares |
|
28/09/2001 |
Interim Results announcement for the six months ended 30 June 2001 |
|
16/07/2001 |
Shares in Issue: 52.54m 5p Ordinary shares |
|
11/04/2001 |
Colostrinin™ Clinical Trial – Interim Data Assessment |
|
07/04/2001 |
Board Change |
|
19/02/2001 |
Michael Harvey appointed Chief Executive Officer of ReGen Therapeutics Plc |
|